Web Exclusives

CDC gives telebriefing on H3N2v

Access the transcript of an Aug. 10 telebriefing from the Centers for Disease Control and Prevention (CDC), which provided an update on H3N2v infection.…

MedWatch: Product recalls

Recent product recalls include B. Braun Infusomat Space Infusion System, CareFusion Alaris PC Unit, Model 8015, and Dukal Benzalkonium Chloride Antiseptic Wipes. Read about…

FDA approves new weight-loss drug

On July 17, the U.S. Food and Drug Administration (FDA) approved Qsymia (phentermine and topiramate extended-release) as an addition to a reduced-calorie diet and…

CMS awards funding for APRN training

On July 30, the Centers for Medicare & Medicaid Services (CMS) announced the participants for a new initiative that provides funds to support clinical…

FDA approves new COPD treatment

On July 23, the U.S. Food and Drug Administration (FDA) approved Tudorza Pressair (aclidinium bromide) for the long-term maintenance treatment of bronchospasm in patients…

CDC gives telebriefing on H3N2v

Access the transcript of an Aug. 10 telebriefing from the Centers for Disease Control and Prevention (CDC), which provided an update on…

MedWatch: Product recalls

Recent product recalls include B. Braun Infusomat Space Infusion System, CareFusion Alaris PC Unit, Model 8015, and Dukal Benzalkonium Chloride Antiseptic Wipes.…

FDA approves new weight-loss drug

On July 17, the U.S. Food and Drug Administration (FDA) approved Qsymia (phentermine and topiramate extended-release) as an addition to a reduced-calorie…

FDA approves new COPD treatment

On July 23, the U.S. Food and Drug Administration (FDA) approved Tudorza Pressair (aclidinium bromide) for the long-term maintenance treatment of bronchospasm…

Poll

Preferred way to get content

What is your preferred way to consume healthcare content?

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • This field is hidden when viewing the form

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.